Why the study?
Cardiomyopathy is a rare but life-threatening complication of Graves' disease that predominantly affects middle-aged and elderly patients.
Highlights the rare but life-threatening complication of dilated cardiomyopathy in a pediatric patient with Graves' disease, emphasizing the importance of early recognition and treatment.
Dilated cardiomyopathy may complicate pediatric Graves’ disease with thyroid storm; case report leaves open true incidence and screening needs.
Grave’s disease (GD) is the most common cause of hyperthyroidism in children and typically patients exhibit symptoms of hyperthyroidism such as palpitations, sweating, heat intolerance, diarrhoea and weight loss. Cardiomyopathy is a rare but serious and life-threatening complication of GD. It is more prevalent among middle-aged and elderly patients with pre-existing heart conditions. We describe a case of an 11-year-old girl with Graves’ disease complicated by thyroid storm, and dilated cardiomyopathy. She had palpitations for almost 2 years, followed by recurrent syncopal attacks for 6 months. The initial thyroid function test showed significantly high FT4 levels of 85.6pmol/L and suppressed TSH. Her TSH Receptor antibody (TRAB) was positive and her CXR revealed cardiomegaly. She received anti-thyroid drugs including oral Carbimazole, oral propranolol, Lugol’s iodine and intravenous hydrocortisone. Two anti-failure medications were used to treat her heart failure. Her symptoms improved, and she was discharged with oral carbimazole and oral propranolol. It is important to recognise and diagnose the complications associated with severe GD to prevent future cardiac decompensation during relapse. Medical practitioners need to be aware of the rare presentations of Graves’ disease to avoid delayed diagnosis and treatment.
No takes yet. Share an insight, caveat, or question.
Idris et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: